Five Prime Therapeutics: R&D Day 2015 (Five Prime Therap) - May 11, 2015 - “AMG337: Responses in Patients With MET-Amplified GEJ/Gastric/Esophageal Cancer”; “13 patients with MET-amplified GEJ/gastric/esophageal cancer treated to date; ORR = 8/13 (62%)"
P2 data • Gastric Cancer • Oncology
|